<GlossaryTerm id="CDR0000410755"><TermName>PEG-Intron</TermName><TermPronunciation>(… IN-tron)</TermPronunciation><TermDefinition><DefinitionText>A drug that is no longer available in the United States that contains the active ingredient peginterferon alfa-2b and was used to treat chronic hepatitis C.  PEG-Intron is a type of cytokine and a type of immunomodulating agent.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000732982" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;PEG-Intron&quot;" language="en" id="_3"/><MediaLink ref="CDR0000732981" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;PEG-Intron&quot;" language="es" id="_4"/><SpanishTermName>PEG-Intron</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento, no disponible en los Estados Unidos, que contiene el principio activo peginterferón α-2b y se usaba para el tratamiento de la hepatitis C crónica. PEG-Intron es un tipo de citocina y de inmunomodulador.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2005-03-24</DateFirstPublished><DateLastModified>2023-04-06</DateLastModified></GlossaryTerm>
